Perfint Healthcare, a Chennai, India-based medical equipment company focused on developing intelligent solutions in the Interventional Oncology space, has secured US$7.2m in series B venture capital funding.
The round was led by Norwest Venture Partners (NVP), with participation from existing investors, Accel Partners (India) and IDG Ventures.
The company, which was founded in 2005 by S Nandakumar and a team of healthcare device professionals, will use the new capital to complete development of its innovative Interventional Oncology Assistance products and further expand its presence in Southeast Asia, Middle East, Europe and the United States.
In conjunction with the funding Mohan Kumar, executive director of NVP India, will join Perfint‟s board of directors.
Perfint’s flagship product, PIGA CT, is a high tech medical robotic positioning device that assists in clinical applications such as biopsy, FNAC, Drug Delivery, Ablation etc., of small tumors in the lung, abdomen and pelvis.
Certified to International Quality, Safety & Regulatory standards like ISO 13485, IEC / UL 60601-1 and CE marking, PIGA CT is installed in top medical institutions throughout the country including All India Institute of Medical Sciences (AIMS).